Menu

Hot Flashes 0304

Enroll Now

  • This field is for validation purposes and should be left unchanged.

Type of Study:

Hot Flashes

Title of Study:

This study is for women in menopause with hot flashes

Short Title:

A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause

Study Length: This study will consist of a screening period and a 52-week treatment period. Safety follow up will occur 3 weeks after the last dose of study drug

Target Age/Sex: 40 Years to 65 Years , Female

Benefits:

Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov